CELH
Bullish signal
Factor checklist — research, not advice
A check leans with a bullish reading. A cross leans against it. A dash is unavailable or mixed.
- Insider Supports a bullish reading. Open-market purchases outweigh sales
- Congress Unavailable or mixed. No purchase disclosures in the stored window
- Financial indicators Supports a bullish reading. Current ratio 1.68 · operating margin 19%
- Narrative Pulls against a bullish reading. Stored narrative reading is in the bearish band
- Timing Pulls against a bullish reading. Interesting trend — weekly bias down
ACHAT TOTAL: 18000 titres (~493843 USD)
- Insiders
- Fieldly John
- Total bought
-
$493,843
Avg buy (VWAP, 90d window) $27.73 vs last close $27.99 (+0.9%)
- Total sold
-
—
Avg sell (VWAP, 90d window) —
- Last activity
- 2026-09-10
- Liquidity
- Liquid $204,912,961/day · 20d vol
- Last synced
-
2026-09-25 21:10:15
Sign in to request a sync of this company's price history and timing levels.
Insider holdings as a share of total assets aren't available for this company.
Avg buy and avg sell are volume-weighted prices (sum of shares × price, divided by shares) for Form 4 rows in this 90-day window that report both figures. A comparison with last close is market context for that average, not advice.
Recent Form 4
Filings in the 90-day window for this company. Value is shares × price from the filing. Research, not advice.
| Date | Person | Side | Shares | Price | Value | Form 4 |
|---|---|---|---|---|---|---|
| 2026-09-15 | Kravitz Hal | Buy | 12,000 | $28.00 | $336,000 | Form 4 |
| 2026-09-15 | DeSantis Damon | Buy | 16,000 | $27.95 | $447,200 | Form 4 |
| 2026-09-14 | DeSantis Damon | Buy | 20,000 | $27.65 | $553,000 | Form 4 |
| 2026-09-10 | Fieldly John | Buy | 18,000 | $27.44 | $493,843 | Form 4 |
Price (1 year)
Live chart from TradingView — independent market data, as price context around the filings, not the Quorum score. EMA 50/200 and Bollinger load by default. When the exchange is known it is sent as EXCHANGE:SYMBOL; otherwise TradingView resolves the ticker best-effort.
Market snapshot
Signal
Bullish signalScored 2026-09-20
CELH presents a deeply unfavorable risk/reward profile: deteriorating fundamentals (margin compression, DSO spike, liquidity ratio halved) are compounded by a near-absent catalyst score of 20 with no actionable event.
The first sentence of the analysis written for CELH on 2026-09-20 - a real excerpt, not a sample. The rest of it, the 0-100 score and the rating it produced are part of Plus. See plans.
Financial ratios
| Metric | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|---|
| Gross Profit Margin | 50.4% | 50.2% | 48.0% | 41.4% | 40.8% | |
| Ebit Margin | 6.9% | 14.4% | 22.1% | -23.4% | -1.3% | |
| Ebitda Margin | 8.1% | 14.9% | 22.4% | -23.1% | -0.9% | |
| Operating Profit Margin | 18.6% | 11.5% | 20.2% | -24.1% | -1.3% | |
| Pretax Profit Margin | 5.0% | 14.4% | 22.1% | -23.4% | -1.3% | |
| Continuous Operations Profit Margin | 4.3% | 10.7% | 17.2% | -28.7% | 1.3% | |
| Net Profit Margin | 4.3% | 10.7% | 17.2% | -28.7% | 1.3% | |
| Bottom Line Profit Margin | 2.5% | 7.9% | 13.8% | -30.4% | 1.3% | |
| Current Ratio | 1.679 | 3.624 | 4.356 | 5.691 | 2.817 | |
| Quick Ratio | 1.366 | 3.265 | 3.527 | 4.617 | 0.764 | |
| Solvency Ratio | 0.063 | 0.281 | 0.514 | -0.519 | 0.054 | |
| Cash Ratio | 0.370 | 2.435 | 2.733 | 3.808 | 0.175 | |
| Price To Earnings Ratio | 182.960 | 57.261 | 69.013 | -41.783 | 1,243.000 | |
| Price To Earnings Growth Ratio | -4.008 | -1.371 | -0.354 | 0.010 | -24.860 | |
| Forward Price To Earnings Growth Ratio | -4.008 | -1.371 | -0.354 | 0.010 | -24.860 | |
| Price To Earnings Diluted Ratio | 182.960 | 58.533 | 70.805 | -41.783 | 1,243.000 | |
| Price To Earnings Diluted Growth Ratio | -4.117 | -1.408 | -0.367 | 0.010 | -27.316 | |
| Price To Book Ratio | 3.657 | 5.027 | 11.559 | 9.103 | 25.352 | |
| Price To Sales Ratio | 4.277 | 4.540 | 9.546 | 12.042 | 17.509 | |
| Price To Free Cash Flow Ratio | 33.267 | 25.698 | 101.647 | 78.770 | -55.172 | |
| Price To Operating Cash Flow Ratio | 29.929 | 23.411 | 89.099 | 72.753 | -56.971 | |
| Debt To Assets Ratio | 0.131 | 0.011 | 0.001 | 0.001 | 0.004 | |
| Debt To Equity Ratio | 0.228 | 0.017 | 0.002 | 0.001 | 0.006 | |
| Debt To Capital Ratio | 0.186 | 0.016 | 0.002 | 0.001 | 0.006 | |
| Long Term Debt To Capital Ratio | 0.186 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Financial Leverage Ratio | 1.741 | 1.443 | 1.411 | 1.413 | 1.447 | |
| Working Capital Turnover Ratio | 2.974 | 1.437 | 1.564 | 1.412 | 2.663 | |
| Operating Cash Flow Ratio | 0.333 | 0.719 | 0.511 | 0.671 | -1.037 | |
| Operating Cash Flow Sales Ratio | 0.143 | 0.194 | 0.107 | 0.166 | -0.307 | |
| Free Cash Flow Operating Cash Flow Ratio | 0.900 | 0.911 | 0.877 | 0.924 | 1.033 | |
| Debt Service Coverage Ratio | 3.806 | 0.000 | 0.000 | 0.000 | 651.125 | |
| Interest Coverage Ratio | 9.566 | 0.000 | 0.000 | 0.000 | -511.250 | |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Operating Cash Flow Coverage Ratio | 0.537 | 12.983 | 64.572 | 88.747 | -70.398 | |
| Capital Expenditure Coverage Ratio | 9.966 | 11.240 | 8.101 | 13.091 | -30.662 | |
| Dividend Paid And Capex Coverage Ratio | 4.879 | 5.166 | 3.146 | 5.466 | -30.662 | |
| Dividend Payout Ratio | 0.348 | 0.190 | 0.121 | -0.062 | 0.000 | |
| Enterprise Value Multiple | 54.205 | 26.121 | 40.100 | -48.144 | -1,969.036 |
Sparkline shows each ratio oldest → newest (left → right).
How the latest year compares
For each ratio: its most recent value, the change versus one year earlier, and versus its 5-year average. ▲ higher ▼ lower
| Metric | Current | vs 1Y ago | vs 5Y avg |
|---|---|---|---|
| Gross Profit Margin | 50.4% | ▲0.2% | ▲4.2% |
| Ebit Margin | 6.9% | ▼-7.5% | ▲3.2% |
| Ebitda Margin | 8.1% | ▼-6.8% | ▲3.8% |
| Operating Profit Margin | 18.6% | ▲7.1% | ▲13.7% |
| Pretax Profit Margin | 5.0% | ▼-9.4% | ▲1.6% |
| Continuous Operations Profit Margin | 4.3% | ▼-6.4% | ▲3.3% |
| Net Profit Margin | 4.3% | ▼-6.4% | ▲3.3% |
| Bottom Line Profit Margin | 2.5% | ▼-5.4% | ▲3.5% |
| Current Ratio | 1.679 | ▼-1.945 | ▼-1.954 |
| Quick Ratio | 1.366 | ▼-1.899 | ▼-1.342 |
| Solvency Ratio | 0.063 | ▼-0.218 | ▼-0.015 |
| Cash Ratio | 0.370 | ▼-2.066 | ▼-1.534 |
| Price To Earnings Ratio | 182.960 | ▲125.699 | ▼-119.130 |
| Price To Earnings Growth Ratio | -4.008 | ▼-2.637 | ▲2.109 |
| Forward Price To Earnings Growth Ratio | -4.008 | ▼-2.637 | ▲2.109 |
| Price To Earnings Diluted Ratio | 182.960 | ▲124.427 | ▼-119.743 |
| Price To Earnings Diluted Growth Ratio | -4.117 | ▼-2.708 | ▲2.523 |
| Price To Book Ratio | 3.657 | ▼-1.369 | ▼-7.282 |
| Price To Sales Ratio | 4.277 | ▼-0.263 | ▼-5.306 |
| Price To Free Cash Flow Ratio | 33.267 | ▲7.569 | ▼-3.575 |
| Price To Operating Cash Flow Ratio | 29.929 | ▲6.517 | ▼-1.715 |
| Debt To Assets Ratio | 0.131 | ▲0.119 | ▲0.101 |
| Debt To Equity Ratio | 0.228 | ▲0.211 | ▲0.177 |
| Debt To Capital Ratio | 0.185 | ▲0.169 | ▲0.143 |
| Long Term Debt To Capital Ratio | 0.185 | ▲0.185 | ▲0.148 |
| Financial Leverage Ratio | 1.740 | ▲0.297 | ▲0.249 |
| Working Capital Turnover Ratio | 2.974 | ▲1.538 | ▲0.964 |
| Operating Cash Flow Ratio | 0.333 | ▼-0.386 | ▲0.094 |
| Operating Cash Flow Sales Ratio | 0.143 | ▼-0.051 | ▲0.083 |
| Free Cash Flow Operating Cash Flow Ratio | 0.900 | ▼-0.011 | ▼-0.029 |
| Debt Service Coverage Ratio | 3.806 | ▲3.806 | ▼-127.180 |
| Interest Coverage Ratio | 9.566 | ▲9.566 | ▲109.903 |
| Short Term Operating Cash Flow Coverage Ratio | 0.000 | 0.000 | 0.000 |
| Operating Cash Flow Coverage Ratio | 0.536 | ▼-12.446 | ▼-18.751 |
| Capital Expenditure Coverage Ratio | 9.966 | ▼-1.274 | ▲7.619 |
| Dividend Paid And Capex Coverage Ratio | 4.879 | ▼-0.287 | ▲7.280 |
| Dividend Payout Ratio | 0.348 | ▲0.159 | ▲0.229 |
| Enterprise Value Multiple | 54.206 | ▲28.085 | ▲433.556 |
Key metrics
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
| Market cap | $10.76B | $6.15B | $12.58B | $7.87B | $5.50B | |
| Enterprise value | $11.03B | $5.28B | $11.83B | $7.26B | $5.49B | |
| EV / Sales | 4.38x | 3.90x | 8.97x | 11.10x | 17.46x | |
| EV / Op. cash flow | 30.68x | 20.10x | 83.76x | 67.09x | -56.82x | |
| EV / Free cash flow | 34.10x | 22.07x | 95.56x | 72.64x | -55.02x | |
| EV / EBITDA | 54.20x | 26.12x | 40.10x | -48.14x | -1969.04x | |
| Net debt / EBITDA | 1.33x | -4.30x | -2.56x | 4.07x | 5.34x | |
| Current ratio | 1.68x | 3.62x | 4.36x | 5.69x | 2.82x | |
| Income quality | 3.33x | 1.81x | 0.62x | -0.58x | -24.53x | |
| Graham number | $11 | $9 | $10 | — | $1 | |
| Graham net-net | -$4 | $3 | $2 | $2 | $0 | |
| Tax burden | 86.4% | 74.4% | 77.7% | 122.7% | -97.0% | |
| Interest burden | 71.9% | 100.0% | 100.0% | 100.0% | 100.2% | |
| Working capital | $732.4M | $959.0M | $928.3M | $756.7M | $169.2M | |
| Invested capital | $3.13B | $1.12B | $981.6M | $794.0M | $204.5M | |
| Return on assets | 2.1% | 8.2% | 14.8% | -15.3% | 1.3% | |
| Operating ROA | 13.6% | 9.4% | 19.3% | -20.5% | -1.8% | |
| Return on tangible assets | 3.8% | 8.6% | 15.0% | -15.7% | 1.4% | |
| Return on equity | 3.7% | 11.8% | 20.8% | -21.7% | 1.8% | |
| Return on invested capital | 10.0% | 8.2% | 16.4% | -14.9% | 1.8% | |
| Return on capital employed | 11.6% | 11.1% | 21.1% | -14.9% | -1.9% | |
| Earnings yield | 1.0% | 2.4% | 1.8% | -2.4% | 0.1% | |
| Free cash flow yield | 3.0% | 3.9% | 1.0% | 1.3% | -1.8% | |
| Capex / Op. cash flow | 10.0% | 8.9% | 12.3% | 7.6% | -3.3% | |
| Capex / Depreciation | 122.5% | 321.6% | 540.4% | 431.1% | 249.2% | |
| Capex / Sales | 1.4% | 1.7% | 1.3% | 1.3% | 1.0% | |
| SG&A / Sales | 31.8% | 38.7% | 27.8% | 65.6% | 42.1% | |
| R&D / Sales | 0.0% | 0.1% | 0.0% | 0.0% | 0.0% | |
| Stock comp / Sales | 1.1% | 1.4% | 1.6% | 3.2% | 11.6% | |
| Intangibles / Total assets | 45.1% | 4.7% | 1.7% | 2.1% | 9.8% | |
| Days sales outstanding | 110d | 73d | 52d | 37d | 48d | |
| Days payables outstanding | 40d | 22d | 23d | 35d | 70d | |
| Operating cycle | 208d | 144d | 174d | 202d | 423d | |
| Cash conversion cycle | 168d | 121d | 151d | 168d | 353d |
Change by theme
Grouped by what each metric measures. Each figure is the change over the period shown — ▲ up ▼ down versus then.
Change over 1 year
Valuation
Market cap ▲+74.8%EV / Sales ▲+12.5%EV / EBITDA ▲+107.5%EV / Op. cash flow ▲+10.581Earnings yield ▼-0.014Graham number ▲+2.812
Profitability
Return on equity ▼-0.082Return on assets ▼-0.061Return on invested capital ▲+0.018Return on capital employed ▲+0.005Operating ROA ▲+0.042Income quality ▲+1.516Tax burden ▲+0.120
Efficiency
Days sales outstanding ▲+36.844Days payables outstanding ▲+18.031Operating cycle ▲+64.733Cash conversion cycle ▲+46.703Capex / Sales ▼-0.003R&D / Sales ▼-0.001
Balance-sheet strength
Current ratio ▼-1.945Net debt / EBITDA ▲+5.632Working capital ▼-226617000.000Invested capital ▲+2009535000.000Intangibles / Total assets ▲+0.404
Change over 5 years
Valuation
Market cap ▲+95.5%EV / Sales ▼-74.9%EV / EBITDA ▲+102.8%EV / Op. cash flow ▲+87.500Earnings yield ▲+0.009Graham number ▲+10.741
Profitability
Return on equity ▲+0.019Return on assets ▲+0.009Return on invested capital ▲+0.082Return on capital employed ▲+0.134Operating ROA ▲+0.154Income quality ▲+27.861Tax burden ▲+1.834
Efficiency
Days sales outstanding ▲+61.633Days payables outstanding ▼-29.911Operating cycle ▼-214.636Cash conversion cycle ▼-184.725Capex / Sales ▲+0.004R&D / Sales n/a
Balance-sheet strength
Current ratio ▼-1.138Net debt / EBITDA ▼-4.008Working capital ▲+563191000.000Invested capital ▲+2925354000.000Intangibles / Total assets ▲+0.353
Employee count
Peer market caps
Congressional trades
STOCK Act disclosures (90-day window)
Amounts are STOCK Act brackets as disclosed. Quorum does not turn a bracket into an exact price or a midpoint.
No STOCK Act disclosures for this company in this window.
Recent trades
| Date | Representative | Type | Amount |
|---|---|---|---|
| 2025-01-12 | Robert P. Bresnahan | Sale (Full) | $1,001 - $15,000 |
| 2024-09-15 | Josh S. Gottheimer | Sale (Full) | $1,001 - $15,000 |
| 2023-12-03 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2023-11-20 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2023-11-02 | Josh S. Gottheimer | Purchase | $1,001 - $15,000 |
| 2023-01-30 | Daniel Goldman | Sale (Full) | $1,001 - $15,000 |
Recent news
- 2026-09-11 Celsius Holdings, Inc. Securities Fraud Class Action Result of Health and Marketing Misrepresentations and Over 7% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC Celsius Holdings, Inc. Securities Fraud Class Action Result of Health and Marketing Misrepresentations and Over 7% Stock Decline - Investors may Contact Lewis K
- 2026-09-11 Celsius Holdings, Inc. Securities Fraud Class Action Result of Health and Marketing Misrepresentations and Over 7% Stock Decline - Investors may Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC NEW YORK and NEW ORLEANS, Sept. 11, 2026 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C.
- 2026-09-11 Celsius Holdings Inc. (CELH) Outperforms Broader Market: What You Need to Know In the latest trading session, Celsius Holdings Inc. (CELH) closed at $27.22, marking a +2.22% move from the previous day.
- 2026-09-11 Bronstein, Gewirtz & Grossman LLC Urges Celsius Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm New York, New York--(Newsfile Corp. - September 11, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Celsius securities between February 21, 2025 and June 3, 2026, both dates inclusive (the "Class Period").
- 2026-09-10 Celsius Holdings, Inc. Securities Fraud Class Action Result of Health and Marketing Misrepresentations and Over 7% Stock Decline - Investors May Contact Lewis Kahn, Esq., at Kahn Swick & Foti, LLC NEW YORK & NEW ORLEANS--(BUSINESS WIRE)--Kahn Swick & Foti, LLC (“KSF”) and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors with substantial losses that they have until November 3, 2026 to file lead plaintiff applications in a securities class action lawsuit against Celsius Holdings, Inc. (“Celsius” or the “Company”) (NasdaqCM: CELH), if they purchased the Company''s securities between February 21, 2025 and June 3, 2026, inclusive (the “Class Period”.
- 2026-09-10 CELH Class Action Notice: Robbins LLP Reminds Investors of the Lead Plaintiff Deadline in the Celsius Holdings, Inc. Class Action Lawsuit SAN DIEGO, Sept. 10, 2026 (GLOBE NEWSWIRE) -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of all persons and entities who purchased or otherwise acquired Celsius Holdings, Inc. (NASDAQ: CELH) securities between February 21, 2025 and June 3, 2026, inclusive (the "Class Period").
- 2026-09-10 Bronstein, Gewirtz & Grossman LLC Urges Celsius Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm New York, New York--(Newsfile Corp. - September 10, 2026) - Bronstein, Gewirtz & Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed against Celsius Holdings, Inc. (NASDAQ: CELH) and certain of its officers. This lawsuit seeks to recover damages against Defendants for alleged violations of the federal securities laws on behalf of all persons and entities that purchased or otherwise acquired Celsius securities between February 21, 2025 and June 3, 2026, both dates inclusive (the "Class Period").
- 2026-09-10 Bronstein, Gewirtz & Grossman LLC Urges Celsius Holdings, Inc. Investors to Act: Class Action Filed Alleging Investor Harm /PRNewswire/ -- Bronstein, Gewirtz and Grossman, LLC, a nationally recognized investor-rights law firm, announces that a class action lawsuit has been filed
- 2026-09-10 Celsius Stock Edges Lower: What''s Happening? Shares of Celsius Holdings Inc. (NASDAQ:CELH) are trading lower Thursday morning as investors weigh management''s cautious commentary regarding ongoing core-brand volume pressure and margin headwinds.
- 2026-09-10 Pomerantz Law Firm Announces The Filing of a Class Action Against Celsius Holdings, Inc. and Certain Officers - CELH NEW YORK, Sept. 10, 2026 /PRNewswire/ -- Pomerantz LLP announces that a class action lawsuit has been filed against Celsius Holdings, Inc. ("Celsius" or the "Company") (NASDAQ: CELH) and certain officers.